文献速递关节外科

2-辛基氰基丙烯酸酯医用胶与皮内缝合在全膝关节置换术后皮肤闭合中的比较:同一患者随机对照试验

2-Octyl Cyanoacrylate Topical Adhesive as an Alternative to Subcuticular Suture for Skin Closure After Total Knee Arthroplasty: A Randomized Controlled Trial in the Same Patient.
PubMed 文献 · J Arthroplasty · 2021-05-03

这项前瞻性双盲随机对照试验在51例同日双侧全膝关节置换术患者中,将一侧膝随机分配至Dermabond Prineo医用胶,另一侧膝分配至皮内缝合。结果显示,术后6个月两组的温哥华瘢痕评分和患者与观察者瘢痕评估量表无显著差异;医用胶组皮肤缝合时间和拆线时间显著更短,拆线疼痛视觉模拟评分和伤口并发症无显著差异,术后早期伤口边缘对合更优。

要点

  • Dermabond Prineo医用胶与皮内缝合在术后6个月瘢痕评分无显著差异。
  • 医用胶组缝合时间(191秒±60.1秒)和拆线时间(4秒±1.3秒)显著短于皮内缝合组。

核心结论

  • Dermabond Prineo医用胶可更快完成伤口闭合、缩短拆线时间,并在术后早期提供更好的伤口边缘对合,但远期美容效果与皮内缝合相似。
  • 基于本研究,Dermabond Prineo是全膝关节置换术患者中皮内缝合的一种有用替代选择。

研究设计与样本

  • 前瞻性、双盲随机对照试验,纳入51例计划接受同日双侧全膝关节置换术的患者。
  • 每例患者一侧膝随机分配至Dermabond Prineo医用胶,另一侧膝分配至皮内缝合。

主要发现

  • 术后6个月温哥华瘢痕评分和患者与观察者瘢痕评估量表两组无显著差异。
  • 术后2周Hollander伤口评估量表总分两组无显著差异,但Dermabond Prineo组在边缘台阶项上表现更好。
  • 术后6个月美容视觉模拟评分两组无差异。

关键数值与推荐

  • 主要结局:术后6个月温哥华瘢痕评分;术后2周、6周、3个月和6个月的患者与观察者瘢痕评估量表。
  • 次要结局:Hollander伤口评估量表、美容视觉模拟评分、皮肤缝合时间、拆线时间、拆线疼痛视觉模拟评分及6个月随访期间伤口并发症。
  • 证据等级:治疗性1级。

临床怎么用

  • 在需快速闭合伤口、减少拆线操作时间或希望早期伤口边缘对合更佳的全膝关节置换术患者中,可考虑使用Dermabond Prineo医用胶替代皮内缝合。
  • 选择医用胶时需权衡其与皮内缝合相似的远期美容效果及无显著差异的伤口并发症风险。

局限性

  • 样本量较小(51例患者),可能影响结果的普遍性。
  • 研究仅针对同日双侧全膝关节置换术患者,结论外推至其他手术人群需谨慎。
  • 随访时间为6个月,缺乏更长期的美容效果和安全性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 2-octyl cyanoacrylate topical adhesive with flexible self-adhesive polyester mesh (Dermabond Prineo) is becoming widely used in many surgical fields. However, no prior studies have tested the efficacy and safety of this topical adhesive compared with subcuticular suture in the same patient. The purpose of this study was to compare the efficacy and safety between Dermabond Prineo and subcuticular suture for skin closure in patients undergoing same-day bilateral total knee arthroplasties (TKAs). MATERIALS AND METHODS: A prospective, double-blind randomized controlled trial was performed in 51 patients scheduled to undergo same-day bilateral TKAs. One knee was randomly assigned to the Dermabond Prineo and the other knee was allocated to the subcuticular suture. As primary outcomes, Vancouver scar scale was evaluated at 6 months and Patient and Observer Scar Assessment Scale was evaluated at 2 weeks, 6 weeks, 3 months, and 6 months. Secondary outcomes included cosmesis efficacy (Hollander wound evaluation scale [HWES] and cosmesis visual analog scale [VAS]), time and pain efficiency (skin suture time, stitch out time, and stitch out pain VAS), and safety (wound complications during the 6-month follow-up period). The primary and secondary outcome measures were compared between groups. RESULTS: There were no significant differences in Vancouver scar scale and Patient and Observer Scar Assessment Scale at 6 months. Although there were no significant differences in HWES at 2 weeks, the Dermabond Prineo group showed better step-off border item of HWES. There was also no difference in cosmesis VAS at 6 months. The Dermabond Prineo group showed superior results in terms of time (suture time: Dermabond Prineo = 191 second (sec) ± 60.1 sec, subcuticular suture = 356.8 sec ± 92.3 sec; stitch out time: Dermabond Prineo = 4 sec ± 1.3 sec, subcuticular suture = 26.6 sec ± 4.2 sec, all P < .001) without significant differences in pain scale (P = .823) or wound complications (all P > .05). CONCLUSION: Comparing cosmetic efficacy, time efficiency, and safety, Dermabond Prineo provided quicker wound closure, shorter stitch out time, and better wound margin coaptation in the early postoperative period but similar cosmetic efficacy compared with subcuticular suture. Based on our study, Dermabond Prineo is a useful alternative to subcuticular suture in patients undergoing TKA. LEVEL OF EVIDENCE: Therapeutic level 1.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Choi KY, Koh IJ, Kim MS, et al. 2-Octyl Cyanoacrylate Topical Adhesive as an Alternative to Subcuticular Suture for Skin Closure After Total Knee Arthroplasty: A Randomized Controlled Trial in the Same Patient. J Arthroplasty. 2021. PMID: 34024693. doi:10.1016/j.arth.2021.04.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。